Molina Healthcare (NYSE:MOH) Insider Jeff Barlow Sells 8,000 Shares of Stock

Molina Healthcare, Inc (NYSE:MOH) insider Jeff Barlow sold 8,000 shares of the company’s stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $203.07, for a total transaction of $1,624,560.00. Following the completion of the sale, the insider directly owned 59,313 shares of the company’s stock, valued at $12,044,690.91. This represents a 11.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.

Molina Healthcare Trading Down 0.2%

Molina Healthcare stock traded down $0.48 during midday trading on Friday, hitting $209.37. 362,848 shares of the stock were exchanged, compared to its average volume of 997,807. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.95. The stock’s 50-day simple moving average is $202.56 and its 200 day simple moving average is $185.69. Molina Healthcare, Inc has a fifty-two week low of $121.06 and a fifty-two week high of $244.89. The stock has a market capitalization of $10.93 billion, a price-to-earnings ratio of -218.09, a PEG ratio of 12.38 and a beta of 0.75.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Wednesday, October 21st. The company reported $0.89 earnings per share for the quarter, beating the consensus estimate of $0.79 by $0.10. Molina Healthcare had a negative net margin of 0.11% and a positive return on equity of 2.50%. The company had revenue of $11.08 billion for the quarter, compared to analyst estimates of $10.86 billion. During the same period in the previous year, the business posted $1.84 EPS. Molina Healthcare’s revenue was down 3.4% on a year-over-year basis. On average, equities analysts anticipate that Molina Healthcare, Inc will post 5.30 EPS for the current year.

Analysts Set New Price Targets

MOH has been the subject of several analyst reports. JPMorgan Chase & Co. increased their price objective on Molina Healthcare from $220.00 to $225.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 27th. Truist Financial reduced their target price on Molina Healthcare from $250.00 to $225.00 and set a “hold” rating on the stock in a research report on Friday, July 24th. Wells Fargo & Company decreased their price target on Molina Healthcare from $235.00 to $220.00 and set an “equal weight” rating on the stock in a research note on Tuesday, July 28th. Weiss Ratings upgraded Molina Healthcare from a “sell (d)” rating to a “sell (d+)” rating in a report on Wednesday, October 21st. Finally, Deutsche Bank reiterated a “hold” rating and set a $163.00 price target on shares of Molina Healthcare in a report on Monday, October 26th. Three equities research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $213.88.

Top Molina Healthcare Stories

These are some of the MOH stories that stood out recently:

• Negative Sentiment: Zacks Research lowered its EPS estimates for Q1 2027 to $2.48 from $2.53, Q3 2027 to $2.17 from $2.23, and Q3 2028 to $3.85 from $4.06. The analyst firm maintained a Hold rating; the downward revisions may weigh on sentiment about Molina’s earnings outlook.
• Negative Sentiment: Three insiders reported selling a combined 10,382 shares for about $2.11 million, reducing their individual holdings by roughly 6% to 12%. These sales may be viewed as a negative signal, though insider transactions alone do not establish a change in the company’s fundamentals. Jeff Barlow SEC filing Richard Schapiro SEC filing Dale Wolf SEC filing

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Fortitude Family Office LLC raised its holdings in shares of Molina Healthcare by 63.7% in the 3rd quarter. Fortitude Family Office LLC now owns 131 shares of the company’s stock valued at $25,000 after buying an additional 51 shares during the period. Elevation Wealth Partners LLC boosted its holdings in Molina Healthcare by 118.2% during the 2nd quarter. Elevation Wealth Partners LLC now owns 144 shares of the company’s stock valued at $33,000 after acquiring an additional 78 shares during the period. Global Retirement Partners LLC purchased a new position in Molina Healthcare during the 2nd quarter valued at about $39,000. Versant Capital Management Inc boosted its holdings in Molina Healthcare by 341.6% during the 2nd quarter. Versant Capital Management Inc now owns 340 shares of the company’s stock valued at $78,000 after acquiring an additional 263 shares during the period. Finally, Contravisory Investment Management Inc. acquired a new position in Molina Healthcare in the 2nd quarter valued at about $89,000. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Molina Healthcare Company Profile

Molina Healthcare, Inc. is a managed care company that provides health insurance plans primarily to people covered by government-sponsored programs. Its offerings include Medicaid plans, Medicare plans for eligible individuals and dual-eligible members, and health plans sold through government marketplaces under the Affordable Care Act. The company was founded in 1980 by physician C. David Molina in Long Beach, California, initially serving low-income families through community clinics. It later shifted its focus to providing managed health care, with Medicaid becoming a central part of its business.